Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scott_jiminez who wrote (1938)	11/3/2000 11:34:10 AM
From: Mark Bong	Read Replies (2) of 52153

CDIC is a good comparison. Only sales and profit seem to be able to drive CDIC's price. Keep track of it as a comparison. There are a lot of hurdles to breaking into hospital and medical markets. Do they have partners. Can their equipment be put into hospital modules. Is there a reimbursable mechanism in place that is cost effective to medical institutions or doctors. Is it quick or easy to use. Are their recurring costs for each treatment to HDI? When you know the answers to these questions, it will be easier to value the firm and project the timing of stock appreciation. Good Luck.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next